TPI-1020
- Generic Name
- TPI-1020
Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients
- First Posted Date
- 2007-06-07
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Syntara
- Target Recruit Count
- 62
- Registration Number
- NCT00483743
- Locations
- π¨π¦
CHUS -Hopital FLEURIMONT, Sherbrooke, Quebec, Canada
π¨π¦Clinique Medical Les Saules, Les Saules, Quebec, Canada
π¨π¦Firestone Institute for Respiratory Health, Hamilton, Ontario, Canada
Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma
- First Posted Date
- 2006-05-19
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Syntara
- Target Recruit Count
- 27
- Registration Number
- NCT00327808
- Locations
- π¨π¦
Montreal Chest Institute, Montreal, Quebec, Canada
π¨π¦McMaster University Hospital, Hamilton, Ontario, Canada
π¨π¦CARL, Laval, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath